VPT logo

Ventripoint Diagnostics Ltd. Stock Price

TSXV:VPT Community·CA$15.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

VPT Share Price Performance

CA$0.085
-0.04 (-34.62%)
CA$0.085
-0.04 (-34.62%)
Price CA$0.085

VPT Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with imperfect balance sheet.

4 Risks
0 Rewards

Ventripoint Diagnostics Ltd. Key Details

CA$135.8k

Revenue

CA$0

Cost of Revenue

CA$135.8k

Gross Profit

CA$4.7m

Other Expenses

-CA$4.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.027
100.00%
-3,356.55%
-50.1%
View Full Analysis

About VPT

Founded
n/a
Employees
n/a
CEO
Hugh MacNaught
WebsiteView website
ventripoint.com

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

Recent VPT News & Updates

Recent updates

No updates